Fig. 1: Centres reported the absolute numbers of patients delayed in receiving CAR T-cell therapy during 2020 up to the point of survey submission. | Bone Marrow Transplantation

Fig. 1: Centres reported the absolute numbers of patients delayed in receiving CAR T-cell therapy during 2020 up to the point of survey submission.

From: Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT

Fig. 1

These data are depicted (a) stratified by the total CAR T activity for that centre in 2019 (pre-pandemic). The number of patients expected to have been treated in 2020 up to the point of survey submission was calculated based on reported CAR T activity in 2019. For each centre, a ratio of delayed to the expected number of treated patients was calculated. This is depicted (b), against the total country-specific cases of COVID-19 per million population at the point of survey reporting (data obtained from Our World in Data https://ourworldindata.org/coronavirus#coronavirus-country-profiles).

Back to article page